Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices.
WTO, WHO, WIPO Symposium To Look At Innovative Technologies And UN SDGs 22/01/2018 by William New, Intellectual Property Watch Leave a Comment Three major international organisations in Geneva dealing with health, trade and intellectual property rights will come together next month to look at how innovative technologies can help to achieve the UN Sustainable Development Goals related to health.
New WHO Director Calls On Board To Join In “Intensive” Period Of Change 22/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment All human beings should receive the health services they need without suffering financial hardship, such is the definition of universal health coverage, a key point of discussion at the World Health Organization Executive Board meeting this week. New WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) opened the event by presenting his vision for the future, and the collective work to accomplish necessary changes to the UN health agency. The European Union and United States warned against politicisation of the WHO.
US Working To Block UN High-Level Panel On Access To Medicines Ideas In Geneva And Capitals 22/01/2018 by William New, Intellectual Property Watch Leave a Comment The United States, possibly working with like-minded countries, is working to prevent the further spread among international organisations in Geneva of recommendations put forward by the 2016 United Nations High-Level Panel on Access to Medicines, considering them to be ideological driven and dangerous to economic growth. The comments were made by a US official speaking to a recent US industry event in Washington DC involving many of the US intellectual property attachès, at which two attachés from Geneva described latest developments and strategy for the coming year. A key message from attachès to industry: come to Geneva and engage, starting with this week’s Executive Board meeting at the World Health Organization.
Julia Reda-Led Panel Discussion Reveals – Publishers’ Right Faces High Resistance From Academic Circles 21/01/2018 by Intellectual Property Watch 2 Comments The Greens/EFA Group in the European Parliament organised last autumn the panel discussion titled, “Better Regulation for Copyright: Academics Meet Policy Makers” in Brussels. This is an initiative that together with a recently published study questions whether national and EU neighbouring rights for publishers are actually lawful. The article below gives an overview of the panel discussion and movements that followed in the legislative process in Brussels, with a special focus on the press publishers right, writes Ines Duhanic.
Moving Landscape In The IP World – Organisations, Industry, Law Firms 19/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The end of 2017 and start of 2018 brought a lot of changes in the global intellectual property arena. The World Health Organization underwent major changes in its leadership following a new head elected in May, UNAIDS has a new deputy executive director, the World Intellectual Property Organization is seeking a new leader of its Global Challenges division, and the Board of the Internet Corporation for Assigned Names and Numbers decided on a number of appointments. The European Patent Office elected a new president, and the industry world also saw its share of changes. The International Federation of Pharmaceutical Manufacturers and Associations welcomed some new faces, and the head of the Federation of the European Sporting Goods Industry is changing. Law firms saw a high level of revolving chair movements, and promotions of attorneys to partners.
Antimicrobial Resistance The “Scariest” Public Health Issue, Needs Financial R&D Incentives, Industry Says 19/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment On the eve of the annual January World Health Organization Executive Board meeting, an alliance of pharmaceutical industries launched its first report on efforts made to curb antimicrobial resistance. The alliance also organised a conference on the report and on challenges of antimicrobial resistance, in particular the need for research and development incentives so that the industry can continue its efforts sustainably. Some light was also shed on the need to support access to diagnostics, and lower their prices.
Heading Off Global Action On Access To Medicines In 2018 19/01/2018 by Intellectual Property Watch Leave a Comment At the dawn of 2018, political and health leaders must seize the growing momentum and opportunities to tackle the protracted challenges of access to medicines that undermines efforts to save lives and improve health as committed under the Agenda 2030 SDG [Sustainable Development Goals] by all UN member states, write Jorge Bermudez and Viroj Tangcharoensathien.
Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed.
EPO-EU Conference Examines Hot Topic Of Patentability Of Plants In Europe 18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The last couple of years have brought heated discussions in Europe on the patentability of plant innovations, leading to a recent amendment of patent application rules at the European Patent Office. Two major actors share this innovation landscape: the biotechnologists and the plant breeders, with similar but not identical needs for protecting their invention. A joint conference on innovation in the plant sector was held recently by the EPO and the Community Plant Variety Office.